Coherus BioSciences Inc CHRS Pharmaceuticals Healthcare Deals and Alliances...
SummaryCoherus BioSciences Inc Coherus BioSciences formerly known as BioGenerics Inc is a biosimilar platform company that develops and commercializes biosimilar drugs. The company's pipeline product...
View ArticleMKSAP 22yearold woman is evaluated for a flare of Crohn disease
Test your medicine knowledge with theÂMKSAP challenge in partnership with theÂAmerican College of Physicians. A 22yearold woman is evaluated for a flare of Crohn disease. A colonoscopy performed 6...
View ArticleTillotts Pharma AG Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryTillotts Pharma AG Tillotts a subsidiary of Zeria Pharmaceutical Co Ltd is a healthcare solution provider that develops licenses and markets pharmaceutical products medical devices and...
View ArticleDiscovery of Potent Parasite Protein May Lead to New Therapeutic Options for...
A single protein from a worm parasite may one day offer new therapeutic options for treating inflammatory bowel diseases like Crohn’s or Ulcerative Colitis that avoid the potentially serious...
View Article4SC receives milestone payment from Immunic
DGAPNews 4SC AG Key words Alliance13.12.2017 0730 The issuer is solely responsible for the content of this announcement.4SC receives milestone payment from Immunic PlaneggMartinsried Germany 13...
View ArticleResearchers suggest role for MKL1 protein in development of inflammatory...
Inflammatory bowel disease IBD including the two conditions ulcerative colitis and Crohn's disease results in longterm inflammation of the gut and is associated with dysregulation of the immune system.
View ArticleQueens Medical Associates Brightens Patients Holidays with Peruvian Cheer on...
Longtime nurse brings young performers from local dance group to the practiceFRESH MEADOWS N.Y. PRWEB December 13 2017 Queens Medical Associates a preeminent cancer care facility and infusion center...
View ArticleFDA Approves New Pfizer Biosimilar
Pfizerdeveloped biosimilar medicine IXIFI infliximabqbtx receives FDA approval for all eligible indications Pfizer Inc. NYSEPFE announced today that the United States U.S. Food and Drug Administration...
View ArticleFDA approves Ixifi third Remicade biosimilar
The FDA has approved the third biosimilar to infliximab infliximabqbtx for all eligible indications of the biologic product according to a company press release.Ixifi infliximabqbtx Pfizer a biosimilar...
View ArticleGalapagos exercises copromotion option for filgotinib with collaboration...
Equity lockup and standstill arrangement between the companies to expire on 31ÂDecemberÂ2017 Mechelen Belgium; 14 December 2017; 22.01 CETÂ Galapagos NV Euronext & NASDAQ GLPG announced today...
View ArticleMesoblast grants TiGenix an exclusive global patent license to use...
PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION Mesoblast grants TiGenix an exclusive global patent license to use adiposederived mesenchymal stem cells in the local treatment of fistulae New...
View ArticleGalapagos NV GLPG Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryGalapagos NV Galapagos is a biotechnology company that discovers and develops pharmaceutical products. The company's product pipeline encompasses investigational candidates targeted at the...
View ArticleNews and press releases New medicine to treat perianal fistulas in patients...
Alofisel is the tenth advanced therapy recommended for marketing authorisation
View ArticleTakeda and TiGenix announce that Cx601 darvadstrocel has received a positive...
PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION Takeda and TiGenix announce that Cx601 darvadstrocel has received a positive CHMP opinion to treat complex perianal fistulas in Crohn's...
View ArticleFred Hutchinson Cancer Research Center Medical Equipment Deals and Alliances...
SummaryFred Hutchinson Cancer Research Center Fred Hutchinson a subsidiary of National Comprehensive Cancer Network is a nonprofit organization which conducts research on the prevention diagnose and...
View ArticleLa Jolla Institute for Allergy Immunology Pharmaceuticals Healthcare Deals...
SummaryLa Jolla Institute for Allergy Immunology LIAI is a biomedical research institute that offers solutions for infectious agents and cancers. The institute offers research on prevention treatment...
View ArticleCHMP recommends approval of darvadstrocel to treat complex perianal fistulas...
Takeda Pharmaceutical and TiGenix reported that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA in conjunction with the Committee for Advanced Therapies CAT...
View ArticleSeven therapies backed for EU approval
Seven therapies have been put forward for approval in the European Union bringing closer new options for a range of conditions including Crohn’s disease diabetes and cancer.
View ArticleBelgian Biotechs Crohns Disease Cell Therapy Gets Recommended for Approval
An EMA committee has given TiGenix&8217;s allogeneic stem cell therapy for Crohn&8217;s disease its backing to enter the market in Europe. TiGenix and its Japanese partner Takeda are developing...
View ArticleCHMP backs Europes first allogeneic stem cell therapy
Takeda has exUS rights to the Crohn's disease treatment from biotech TiGenix
View Article